sheets were sterilized and human aortic endothelial cells (HAECs)
were trypsinized and seeded at density of 100,000 cells/cm2 in fully supplemented EGM-2 onto collagen sheets or into individual
wells of 6-well plates and allowed to adhere for 48 h. Medium was
then replaced with fully supplemented EGM-2 without serum for 24 h
to achieve a quiescent phenotype. Positive control samples were treated
with TNF-α (100 ng/mL in EGM-2) for 4 h prior to fixation and
staining. Samples were fixed in buffered formalin (10%) for 20 min
at 4 °C, then washed three times with PBS pH 7.4 for 5 min each.
Permeabilization was completed with a 5 min incubation in Triton X-100
(0.3%) in PBS and samples were then washed three times with Triton
X-100 (0.1%) in PBS (PBS-T) for 5 min each. Non-specific binding was
blocked for 30 min at room temperature with a solution of Triton X-100
(0.1%) in PBS containing BSA (2%, Abdil) and then washed three times
with PBS-T for 5 min each. Primary antibodies were utilized at 1:50
dilutions (ICAM-1, VCAM-1 (Abcam)). Samples were also stained for
F-actin (1:40 from a 6.6 μM stock solution, Life Technologies)
for 1 h following standard protocol. Samples were mounted with Prolong
Antifade containing DAPI (Life Technologies) and stored at 4 °C
until imaging on a Leica SP5 X inverted confocal microscope (Wetzlar,
Germany).